<?xml version="1.0" encoding="utf-8"?><bwFrame xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" default_layout="pxnsnfns11111000110" textdirection="ltr" device="false" kbshortcuts="true" outputtype="ap"><layouts><layout name="pxnsnfns11111000110" font="Articulate" controllayout="pxnsnfns11111000110" colorscheme="pxnsnfns11111000110" string_table="pxnsnfns11111000110" /></layouts><control_options><optiongroups><optiongroup name="sidebaroptions"><options><option name="title_enabled" value="true"><options><option name="title_text" value="Stem Cells 101" /></options></option><option name="logo_enabled" value="true"><options><option name="logo_url" value="presentation_content/logo.swf"><properties><property name="width" value="219" /><property name="height" value="113" /></properties></option><option name="html5_logo_url" value="mobile/6PKHiD1rC3u.jpg" /></options></option><option name="sidebar_enabled" value="true"><options><option name="sidebarpos" value="left" /></options></option><optionlist name="tabs"><listitems><listitem name="resources" value="false" group="linkright" /><listitem name="customlink" value="true" group="linkright"><properties><property name="title" value="Exit" /><property name="data" value="5wDrnIFsiHk" /><property name="ignoreSlideLock" value="true" /></properties></listitem><listitem name="outline" value="true" group="sidebar" /><listitem name="glossary" value="false" group="sidebar" /><listitem name="transcript" value="false" group="sidebar" /></listitems></optionlist><option name="time_enabled" value="false"><options><option name="time_format" value="totalelapsed" /></options></option><option name="info_enabled" value="true"><options><option name="default" value="8QmGefOdlsw" /></options></option><option name="video_enabled" value="false"><options><option name="height" value="135" /></options></option></options></optiongroup><optiongroup name="menuoptions"><options><option name="flow" value="free" /><option name="wraplistitems" value="false" /><option name="tooltips" value="true" /><option name="autocollapse" value="true" /><option name="autonumber" value="true" /><option name="levelbehavior" value="reached" /><option name="levelrestriction" value="unrestricted" /><option name="enableresultsicons" value="false" /></options></optiongroup><optiongroup name="controls"><options><option name="volume" value="true" /><option name="seekbar" value="true"><options><option name="readonly" value="false" /></options></option><option name="search" value="true" /><option name="replay" value="true" /><option name="pauseplay" value="true" /><option name="enableKeyboardShortcuts" value="true" /><option name="elapsedandtotaltime" value="true" /><option name="use_fixed_output_size" value="true" /><option name="output_size_scale_percent" value="100" /></options></optiongroup><optiongroup name="bottombaroptions"><options><option name="bottombar_enabled" value="true" /></options></optiongroup></optiongroups></control_options><control_layouts><control_layout name="pxnsnfns11111000110"><control name="volume" enabled="true" /><control name="seekbar" enabled="true" /><control name="replay" enabled="true" /><control name="pauseplay" enabled="true" /><control name="logo" enabled="true" /><control name="previous" enabled="true" /><control name="next" enabled="true" /><control name="submit" enabled="false" /><control name="finish" enabled="false" /><control name="submitall" enabled="false" /><control name="resources" enabled="false" /><control name="glossary" enabled="false" /><control name="transcript" enabled="false" /><control name="outline" enabled="true"><controls><control name="search" enabled="true" /></controls></control><control name="close_btn" enabled="false" /></control_layout></control_layouts><colorschemes><colorscheme name="pxnsnfns11111000110"><color_group name="infopanel"><group_colors><color name="link_text"><fill type="linear" rotation="90"><colors><color rgb="0x1F497D" alpha="100" stop="0" /></colors></fill></color><color name="link_hover"><fill type="linear" rotation="90"><colors><color rgb="0x0000EE" alpha="100" stop="0" /></colors></fill></color><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xB8B8B8" alpha="100" stop="0" /></colors></fill></color><color name="name_text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color><color name="title_text"><fill type="linear" rotation="90"><colors><color rgb="0x999999" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="infopanelpopup"><group_colors><color name="link_text"><fill type="linear" rotation="90"><colors><color rgb="0x7C2280" alpha="100" stop="0" /></colors></fill></color><color name="link_hover"><fill type="linear" rotation="90"><colors><color rgb="0x0000EE" alpha="100" stop="0" /></colors></fill></color><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xE9E9E9" alpha="100" stop="0" /><color rgb="0xCFCFCF" alpha="100" stop="255" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xB8B8B8" alpha="100" stop="0" /></colors></fill></color><color name="name_text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color><color name="bio_text"><fill type="linear" rotation="90"><colors><color rgb="0x999999" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="timer"><group_colors><color name="duration"><fill type="linear" rotation="90"><colors><color rgb="0x00D7FF" alpha="100" stop="0" /><color rgb="0x00ABFF" alpha="100" stop="255" /></colors></fill></color><color name="elapsed"><fill type="linear" rotation="90"><colors><color rgb="0xFEE347" alpha="100" stop="0" /><color rgb="0xFCCC2A" alpha="100" stop="255" /></colors></fill></color><color name="stroke"><fill type="linear" rotation="90"><colors><color rgb="0xC7C7C7" alpha="100" stop="0" /></colors></fill></color><color name="inner"><fill type="linear" rotation="90"><colors><color rgb="0xFFFFFF" alpha="100" stop="0" /></colors></fill></color><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="window"><group_colors><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color><color name="inner"><fill type="linear" rotation="90"><colors><color rgb="0xEAEAEA" alpha="100" stop="0" /><color rgb="0xCFCFCF" alpha="100" stop="255" /></colors></fill></color><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xF3F3F3" alpha="100" stop="0" /></colors></fill></color><color name="diva"><fill type="linear" rotation="90"><colors><color rgb="0xF7F7F7" alpha="100" stop="0" /></colors></fill></color><color name="divb"><fill type="linear" rotation="90"><colors><color rgb="0xD3D3D3" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0x000000" alpha="20" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="editor"><group_colors><color name="slide_text"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color><color name="html_text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color><color name="btn_bg"><fill type="linear" rotation="90"><colors><color rgb="0xF5F5F5" alpha="100" stop="0" /><color rgb="0xC7C7C7" alpha="100" stop="255" /></colors></fill></color><color name="btn_hover"><fill type="linear" rotation="90"><colors><color rgb="0xF2F2F2" alpha="100" stop="0" /><color rgb="0xAFAFAF" alpha="100" stop="255" /></colors></fill></color><color name="btn_down"><fill type="linear" rotation="90"><colors><color rgb="0xC7C7C7" alpha="100" stop="0" /><color rgb="0xF4F4F4" alpha="100" stop="255" /></colors></fill></color><color name="btn_border"><fill type="linear" rotation="90"><colors><color rgb="0xB1B1B1" alpha="100" stop="0" /></colors></fill></color><color name="btn_text"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="btn_text_shadow"><fill type="linear" rotation="90"><colors><color rgb="0xF0F0F0" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="listitem"><group_colors><color name="selected_text"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="lines"><fill type="linear" rotation="90"><colors><color rgb="0xDFDFDF" alpha="100" stop="0" /></colors></fill></color><color name="hover"><fill type="linear" rotation="90"><colors><color rgb="0xE6E6E6" alpha="100" stop="0" /></colors></fill></color><color name="viewed"><fill type="linear" rotation="90"><colors><color rgb="0x909090" alpha="100" stop="0" /></colors></fill></color><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="selected"><fill type="linear" rotation="90"><colors><color rgb="0xC0E2F1" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xFFFFFF" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="base"><group_colors><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color><color name="diva"><fill type="linear" rotation="90"><colors><color rgb="0x000000" alpha="100" stop="0" /></colors></fill></color><color name="divb"><fill type="linear" rotation="90"><colors><color rgb="0xF7F7F7" alpha="100" stop="0" /></colors></fill></color><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /><color rgb="0xFAF0C8" alpha="100" stop="255" /></colors></fill></color><color name="border"><fill type="linear" rotation="90"><colors><color rgb="0xE9E9E9" alpha="100" stop="0" /><color rgb="0xF3F3F3" alpha="100" stop="255" /></colors></fill></color><color name="menu_shade"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /><color rgb="0xFAF0C8" alpha="100" stop="255" /></colors></fill></color><color name="slide_bg"><fill type="linear" rotation="90"><colors><color rgb="0x000000" alpha="100" stop="0" /><color rgb="0x000000" alpha="100" stop="255" /></colors></fill></color></group_colors></color_group><color_group name="button"><group_colors><color name="btn_bg"><fill type="linear" rotation="90"><colors><color rgb="0xF5F5F5" alpha="100" stop="0" /><color rgb="0xC7C7C7" alpha="100" stop="255" /></colors></fill></color><color name="btn_hover"><fill type="linear" rotation="90"><colors><color rgb="0xF2F2F2" alpha="100" stop="0" /><color rgb="0xAFAFAF" alpha="100" stop="255" /></colors></fill></color><color name="btn_down"><fill type="linear" rotation="90"><colors><color rgb="0xC7C7C7" alpha="100" stop="0" /><color rgb="0xF4F4F4" alpha="100" stop="255" /></colors></fill></color><color name="btn_border"><fill type="linear" rotation="90"><colors><color rgb="0xB1B1B1" alpha="100" stop="0" /></colors></fill></color><color name="btn_text"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="btn_text_shadow"><fill type="linear" rotation="90"><colors><color rgb="0xF0F0F0" alpha="100" stop="0" /></colors></fill></color><color name="btn_icon_color"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="btn_glow"><fill type="linear" rotation="90"><colors><color rgb="0xCFCFCF" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="checkbox"><group_colors><color name="border"><fill type="linear" rotation="90"><colors><color rgb="0xB8B8B8" alpha="100" stop="0" /></colors></fill></color><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xFFFFFF" alpha="100" stop="0" /></colors></fill></color><color name="check"><fill type="linear" rotation="90"><colors><color rgb="0x33CC00" alpha="100" stop="0" /></colors></fill></color><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color><color name="hover"><fill type="linear" rotation="90"><colors><color rgb="0x6BF8FF" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="logo"><group_colors><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="menu"><group_colors><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xF3F3F3" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="scrollarea"><group_colors><color name="bg"><fill type="linear" rotation="0"><colors><color rgb="0xDEDEDE" alpha="100" stop="0" /><color rgb="0xE8E8E8" alpha="100" stop="128" /></colors></fill></color><color name="border"><fill type="linear" rotation="90"><colors><color rgb="0xF6F6F6" alpha="100" stop="0" /><color rgb="0xF3F3F3" alpha="100" stop="255" /></colors></fill></color><color name="button_bg"><fill type="linear" rotation="90"><colors><color rgb="0xC4C4C4" alpha="100" stop="0" /><color rgb="0xB2B2B2" alpha="100" stop="255" /></colors></fill></color><color name="button_inner"><fill type="linear" rotation="90"><colors><color rgb="0xCBCBCB" alpha="100" stop="0" /><color rgb="0xBABABA" alpha="100" stop="255" /></colors></fill></color><color name="button_border"><fill type="linear" rotation="90"><colors><color rgb="0xB8B8B8" alpha="100" stop="0" /></colors></fill></color><color name="icons"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xD9D9D9" alpha="100" stop="0" /></colors></fill></color><color name="detaila"><fill type="linear" rotation="90"><colors><color rgb="0xA7A7A7" alpha="100" stop="0" /></colors></fill></color><color name="detailb"><fill type="linear" rotation="90"><colors><color rgb="0xCFCFCF" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="searchinput"><group_colors><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xDFDFDF" alpha="100" stop="0" /></colors></fill></color><color name="border"><fill type="linear" rotation="90"><colors><color rgb="0xADADAD" alpha="100" stop="0" /><color rgb="0xFAFAFA" alpha="100" stop="255" /></colors></fill></color><color name="icon"><fill type="linear" rotation="90"><colors><color rgb="0x8A8A8A" alpha="100" stop="0" /></colors></fill></color><color name="button_hover"><fill type="linear" rotation="90"><colors><color rgb="0xF5F5F5" alpha="100" stop="0" /><color rgb="0xC7C7C7" alpha="100" stop="255" /></colors></fill></color><color name="hover_glow"><fill type="linear" rotation="90"><colors><color rgb="0x6BF8FF" alpha="100" stop="0" /></colors></fill></color><color name="search_text"><fill type="linear" rotation="90"><colors><color rgb="0x8A8A8A" alpha="100" stop="0" /></colors></fill></color><color name="bg_active"><fill type="linear" rotation="90"><colors><color rgb="0xFAFAFA" alpha="100" stop="0" /></colors></fill></color><color name="text_active"><fill type="linear" rotation="90"><colors><color rgb="0x333333" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="seekcontrol"><group_colors><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xF5F5F5" alpha="100" stop="0" /><color rgb="0xC7C7C7" alpha="100" stop="255" /></colors></fill></color><color name="border"><fill type="linear" rotation="90"><colors><color rgb="0xB1B1B1" alpha="100" stop="0" /></colors></fill></color><color name="seek_border"><fill type="linear" rotation="90"><colors><color rgb="0xB8B8B8" alpha="100" stop="0" /><color rgb="0xEEEEEE" alpha="100" stop="255" /></colors></fill></color><color name="seek_bg"><fill type="linear" rotation="90"><colors><color rgb="0xE7E7E7" alpha="100" stop="0" /></colors></fill></color><color name="seek_position"><fill type="linear" rotation="90"><colors><color rgb="0xFFFFFF" alpha="100" stop="0" /></colors></fill></color><color name="btn_icon_color"><fill type="linear" rotation="90"><colors><color rgb="0x2D2D2D" alpha="100" stop="0" /></colors></fill></color><color name="btn_icon_hover"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color><color name="btn_icon_shadow"><fill type="linear" rotation="90"><colors><color rgb="0xF0F0F0" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="tabs"><group_colors><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xF3F3F3" alpha="100" stop="0" /></colors></fill></color><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x555555" alpha="100" stop="0" /></colors></fill></color><color name="selected"><fill type="linear" rotation="90"><colors><color rgb="0x333333" alpha="100" stop="0" /></colors></fill></color><color name="hover"><fill type="linear" rotation="90"><colors><color rgb="0x333333" alpha="100" stop="0" /></colors></fill></color><color name="shadow"><fill type="linear" rotation="90"><colors><color rgb="0xF0F0F0" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="transcript"><group_colors><color name="div"><fill type="linear" rotation="90"><colors><color rgb="0xE1E1E1" alpha="100" stop="0" /></colors></fill></color><color name="heading_text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="outline"><group_colors><color name="diva"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /></colors></fill></color><color name="divb"><fill type="linear" rotation="90"><colors><color rgb="0xFAF0C8" alpha="100" stop="0" /></colors></fill></color><color name="divc"><fill type="linear" rotation="90"><colors><color rgb="0xE1E1E1" alpha="100" stop="0" /></colors></fill></color><color name="search_text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color><color name="search_hover"><fill type="linear" rotation="90"><colors><color rgb="0x0000EE" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="resource"><group_colors><color name="separator"><fill type="linear" rotation="90"><colors><color rgb="0xE0E0E0" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="glossary"><group_colors><color name="selected_text"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="selected"><fill type="linear" rotation="90"><colors><color rgb="0xC0E2F1" alpha="100" stop="0" /></colors></fill></color><color name="text"><fill type="linear" rotation="90"><colors><color rgb="0x353535" alpha="100" stop="0" /></colors></fill></color><color name="hover"><fill type="linear" rotation="90"><colors><color rgb="0xE6E6E6" alpha="100" stop="0" /></colors></fill></color><color name="diva"><fill type="linear" rotation="90"><colors><color rgb="0xE2E2E2" alpha="100" stop="0" /></colors></fill></color><color name="divb"><fill type="linear" rotation="90"><colors><color rgb="0xE2E2E2" alpha="100" stop="0" /></colors></fill></color><color name="divc"><fill type="linear" rotation="90"><colors><color rgb="0xFAFAFA" alpha="100" stop="0" /></colors></fill></color><color name="bg"><fill type="linear" rotation="90"><colors><color rgb="0xE7E7E7" alpha="100" stop="0" /></colors></fill></color><color name="heading_text"><fill type="linear" rotation="90"><colors><color rgb="0x444444" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group><color_group name="volume"><group_colors><color name="thumb_border"><fill type="linear" rotation="90"><colors><color rgb="0xA5A5A5" alpha="100" stop="0" /></colors></fill></color><color name="thumb_inner"><fill type="linear" rotation="90"><colors><color rgb="0xD4D4D4" alpha="100" stop="0" /></colors></fill></color><color name="thumb_bg"><fill type="linear" rotation="90"><colors><color rgb="0xC8C8C8" alpha="100" stop="0" /></colors></fill></color><color name="slider_border"><fill type="linear" rotation="90"><colors><color rgb="0xF2F2F2" alpha="100" stop="0" /></colors></fill></color><color name="slider_bg"><fill type="linear" rotation="90"><colors><color rgb="0xBCBCBC" alpha="100" stop="0" /><color rgb="0xBCBCBC" alpha="100" stop="128" /><color rgb="0xC3C3C3" alpha="100" stop="255" /></colors></fill></color></group_colors></color_group><color_group name="HTML"><group_colors><color name="htmlpage_bg_color"><fill type="linear" rotation="90"><colors><color rgb="0xA6A6A6" alpha="100" stop="0" /></colors></fill></color></group_colors></color_group></colorscheme></colorschemes><string_tables><string_table name="pxnsnfns11111000110"><string id="prev">PREV</string><string id="next">NEXT</string><string id="submit">SUBMIT</string><string id="outline">Menu</string><string id="resources">Resources</string><string id="glossary">Glossary</string><string id="transcript">Notes</string><string id="clear">Clear and return to Menu</string><string id="search_results">Search Results</string><string id="filter">Filter</string><string id="slide_text_chk">Slide Text</string><string id="transcript_chk">Notes</string><string id="search_in">Search in:</string><string id="check_include">Check to include</string><string id="search">Search...</string><string id="terms">Terms</string><string id="definition">Definition</string><string id="finish">FINISH</string><string id="acc_finish">finish</string><string id="acc_definition">definition</string><string id="acc_resources">resources</string><string id="acc_search_input">search</string><string id="acc_pause">pause</string><string id="acc_play">play</string><string id="acc_replay">replay</string><string id="acc_submit">submit</string><string id="acc_next">next</string><string id="acc_previous">previous</string><string id="acc_volume">volume</string><string id="submitall">SUBMIT ALL</string><string id="acc_submitall">submit all</string><string id="question_list">Question List</string><string id="more_info">More info</string><string id="send_an_email">Send an email</string><string id="close">Close</string><string id="bio">Bio</string><string id="exit">Exit</string></string_table></string_tables><sounds enabled="false" /><nav_data><outline><links><slidelink slideid="4TtrJGaU2VT.6eIZEsmeLAS" displaytext="Stem Cells 101" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5UvnIm26Ocf" displaytext="What and How Do We Define Stem Cells" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6IIgi9vCTI8" displaytext="Stem Cells vs. Progenitor Cells" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.68on8mK15D9" displaytext="Totipotent" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.6kICDQzOpx7" displaytext="Pluripotent or Multipotent" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6d1AoWPqKQl" displaytext="Totipotent" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.6cf6C64oReY" displaytext="Embryonic vs. iPS cells" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6SG8pLSjBsC" displaytext="Hematopoietic Stem Cell" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5geDXr3q44e" displaytext="iPS cells" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.5aTlGlLF5h6" displaytext="Pluripotent" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5XyUNVd0Ys1" displaytext="Bone Marrow" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5k1oD2ncXYO" displaytext="Bone Marrow" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5mQtLfyF2wj" displaytext="Stromal Cell" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.5kDYXr4WF82" displaytext="Mesenchymal Sources" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5l7euLlQuF0" displaytext="Stem Cells vs. Progenitor Cells" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5ZgdTFMrZyO" displaytext="A Stem Cell Journey" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5h89RlrO46G" displaytext="Stem cell populations" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6ghDvHL2xfD" displaytext="How do we define cells? " expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5sK0tyNvDZh" displaytext="What Happens in a Flow Cytometer?" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6f9KDNiFvK0" displaytext="Side Scatter" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.68rlQkqHr4A" displaytext="Why Look at FSC v. SSC" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5ukBVOYHuUO" displaytext="CD Markers" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5v55tH7mvU1" displaytext="CD Markers" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.5huRxAoBxEO" displaytext="Hematopoietic Markers" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5riz34xNm26" displaytext="Hematopoietic Progenitors" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6OhiK1fTLba" displaytext="Markers" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.6MYJzMFQrPD" displaytext="Mesenchymal cells" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5oV8aNoDZ4i" displaytext="Marker Overlap" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5fzRBS29zCz" displaytext="Mesenchymal Stem Cells" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5hc8VW6tux1" displaytext="Differentiated Stem Cells" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5WjjKvVPYUm" displaytext="Mesenchymal Differentiation" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6UB52LjEcRE" displaytext="Mesenchymal Differentiation" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.6qPM8O1s7Q6" displaytext="Cardiac Stem Cell Differentiation" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6lGQaBrdRqb" displaytext="Heart Differentiation Markers" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5dkVQYOko08" displaytext="Markers" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.6GBiioTYGjd" displaytext="Cells in PACE" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6VpO1F1Gyyk" displaytext="Differentiation Potentials in ALDH Bright fraction" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.679kZPE3b5V" displaytext="ALDH Bright fraction" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5XZT6qOTap5" displaytext="Cell Function Assays" expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.5jNuRZOkfl3" displaytext="CFU Hill Assay" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.6q7IHZjzVxu" displaytext="CFC Assay" expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.6bsJAqueoeZ" displaytext="CFU Fibroblast" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5m1eBzwAxLa" displaytext="Example of Using BRC Data  " expand="false" type="slide"><links><slidelink slideid="4TtrJGaU2VT.6CvIU1C45Sy" displaytext="Using BRC Data  " expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5jEZW6i8qmO" displaytext="Using BRC Data  " expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5VbirWS7nB4" displaytext="Using BRC Data  " expand="false" type="slide" /></links></slidelink><slidelink slideid="4TtrJGaU2VT.6SSqfmJe5SE" displaytext="Cell Phenotypes " expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.5dFN5ZTd9kP" displaytext="End Points" expand="false" type="slide" /><slidelink slideid="4TtrJGaU2VT.68JnWGVCHjn" displaytext="Acknowledgment" expand="false" type="slide" /></links></outline><search><slidetext slideid="4TtrJGaU2VT.6eIZEsmeLAS" slidebank="false" type="slide"> stem cells 101 doris taylor, phd, facc, fahaco-director,  biorepository core cctrn</slidetext><slidetext slideid="4TtrJGaU2VT.5UvnIm26Ocf" slidebank="false" type="slide"> what are stem cells and how do we define them with markers in cctrn in 2014? doris taylor phd, faha, faccfor the cctrn brc</slidetext><slidetext slideid="4TtrJGaU2VT.6IIgi9vCTI8" slidebank="false" type="slide"> stem cells vs. progenitor cells stem cells – cells that can self-renew and differentiate into multiple lineages totipotent – can give rise to all three developmental lineages (endoderm, ectoderm and mesoderm) es cells, ips cellspluripotent – can give rise to two or more developmental lineages (hscs, bmcs)multipotent – can give rise to multiple cell types usually within a lineage (mscs)</slidetext><slidetext slideid="4TtrJGaU2VT.68on8mK15D9" slidebank="false" type="slide">   mesenchymal stem cell  hematopoietic stem cell totipotent</slidetext><slidetext slideid="4TtrJGaU2VT.6kICDQzOpx7" slidebank="false" type="slide"> stem cells vs. progenitor cells stem cells – cells that can self-renew and differentiate into multiple lineages totipotent – can give rise to all three developmental lineages (endoderm, ectoderm and mesoderm) es cells, ips cellspluripotent – can give rise to two or more developmental lineages (hscs, bmcs)multipotent – can give rise to multiple cell types usually within a lineage (mscs)</slidetext><slidetext slideid="4TtrJGaU2VT.6d1AoWPqKQl" slidebank="false" type="slide">   mesenchymal stem cell  hematopoietic stem cell totipotent</slidetext><slidetext slideid="4TtrJGaU2VT.6cf6C64oReY" slidebank="false" type="slide"> embryonic vs. ips cells embryonic stem cells – derived from fertilized egg blastocyst inner cell mass (usually at 8-150 cell stage)ips cells – derived from skin bone marrow or blood cells – use 1-4 viruses, genes or mirs to push the cells back to an embryonic stem cell-like fateips cells are marked epigenetically (dna is methylated or demethylated to turn certain genes off or on) so they have the advantages of es cells but the disadvantages of adult scs.</slidetext><slidetext slideid="4TtrJGaU2VT.6SG8pLSjBsC" slidebank="false" type="slide">   mesenchymal stem cell  hematopoietic stem cell totipotent</slidetext><slidetext slideid="4TtrJGaU2VT.5geDXr3q44e" slidebank="false" type="slide"> embryonic vs. ips cells embryonic stem cells – derived from fertilized egg blastocyst inner cell mass (usually at 8-150 cell stage)ips cells – derived from skin bone marrow or blood cells – use 1-4 viruses, genes or mirs to push the cells back to an embryonic stem cell-like fateips cells are marked epigenetically (dna is methylated or demethylated to turn certain genes off or on) so they have the advantages of es cells but the disadvantages of adult scs.</slidetext><slidetext slideid="4TtrJGaU2VT.5aTlGlLF5h6" slidebank="false" type="slide">  gives rise to blood cells (bmc) pluripotent</slidetext><slidetext slideid="4TtrJGaU2VT.5XyUNVd0Ys1" slidebank="false" type="slide">   bone marrow or fat stromal cell</slidetext><slidetext slideid="4TtrJGaU2VT.5k1oD2ncXYO" slidebank="false" type="slide">  gives rise to blood cells (bmc) pluripotent</slidetext><slidetext slideid="4TtrJGaU2VT.5mQtLfyF2wj" slidebank="false" type="slide">   bone marrow or fat stromal cell</slidetext><slidetext slideid="4TtrJGaU2VT.5kDYXr4WF82" slidebank="false" type="slide"> mesenchymal stem cell sources bone marrow (stromal cells)adipose tissueheart stromaalmost any other tissue stromablood (rare)decline with aging 1:10,000 – 1:10,000,000</slidetext><slidetext slideid="4TtrJGaU2VT.5l7euLlQuF0" slidebank="false" type="slide"> progenitor cells – more limited differentiation capacity usually committed to a lineage (e.g., hematopoietic progenitor, endothelial progenitor, cardiac progenitor…) sometimes used just to differentiate by name from a stem cell for non-scientific reasons (mesodermal progenitor vs msc for ip reasons) stem cells vs. progenitor cells</slidetext><slidetext slideid="4TtrJGaU2VT.5ZgdTFMrZyO" slidebank="false" type="slide"> a stem cell journey creation				 		(cardiac 	often during development 	 		progenitor) proliferation	in response to signalmobilization/migration 				(inflammation, toward a signal 					chemokines) commitment to a lineage 			(cardiosphere)differentiation 					(immature 	into a given cell type					cardiocyte)maturation of that cell type			(mature 								cardiocyte) </slidetext><slidetext slideid="4TtrJGaU2VT.5h89RlrO46G" slidebank="false" type="slide"> notes about stem cell populations every population is unique to the individualevery single or double marker population is heterogeneousmultiple markers are needed to narrow down a populationdifferent labs use different definitions of a given stem or progenitor cell (eg epcs)cells are dynamic – they change over time</slidetext><slidetext slideid="4TtrJGaU2VT.6ghDvHL2xfD" slidebank="false" type="slide"> how do we define cells?&#xB;phenotype: flow cytometry&#xB;cluster of differentiation (cd) flow cytometry: characterize and separate cells based on their physical and chemical characteristics. provide multiparameter analyses based on the measurement of visible and fluorescent light emission produced by fluorescent-labeled antibodies that bind to cell-associated molecules. </slidetext><slidetext slideid="4TtrJGaU2VT.5sK0tyNvDZh" slidebank="false" type="slide"> what happens in a flow cytometer? cells in suspension flow single file pasta focused laser where they scatter light and emit fluorescence that is filtered, collectedand converted to digitized values that are stored in a file which can then be read by specialized software. interrogation interrogation  fluidics fluidics  electronics electronics  interpretation interpretation </slidetext><slidetext slideid="4TtrJGaU2VT.6f9KDNiFvK0" slidebank="false" type="slide"> side scatter  fsc&#xB;detector fsc&#xB;detector collectionlens collectionlens      sscdetector    sscdetector      laser beam  laser beam fsc ssc  fsc ssc </slidetext><slidetext slideid="4TtrJGaU2VT.68rlQkqHr4A" slidebank="false" type="slide"> why look at fsc v. ssc since fsc ~ size and ssc ~ internal structure, a correlated measurement between them can allow for differentiation of cell types in a heterogenous cell population fsc ssc  fsc ssc lymphocytes   lymphocytes  monocytes   monocytes  granulocytes   granulocytes  rbcs, debris,dead cells   rbcs, debris,dead cells  </slidetext><slidetext slideid="4TtrJGaU2VT.5ukBVOYHuUO" slidebank="false" type="slide"> cd markers have numbers cd1-cd350were named by the first inter­na­tional workshop on human leukocyte dif­fer­en­ti­ation antigens.many have names that were assigned prior to the cd numbers: cd117 = c-kit	cd309 = vegfr2/kdr/ly-73/flk-1 </slidetext><slidetext slideid="4TtrJGaU2VT.5v55tH7mvU1" slidebank="false" type="slide"> </slidetext><slidetext slideid="4TtrJGaU2VT.5huRxAoBxEO" slidebank="false" type="slide">    cd45-cd133+cd117+ (c-kit+)cd45-cd117+cd45-kdr+cd45-cd105+ hematopoietic stem cell markers</slidetext><slidetext slideid="4TtrJGaU2VT.5riz34xNm26" slidebank="false" type="slide"> hematopoietic&#xB;progenitors cd34+ cd90+ cd133+ cd45+ cd117+cd45dim cd34+cd45dim cd34+ cd117+cd45dim cd34+ cd133+</slidetext><slidetext slideid="4TtrJGaU2VT.6OhiK1fTLba" slidebank="false" type="slide">       cd34 quantification following ishage gating strategy (sutherland et al 1996) cd45 events   cd45 events lkc (10e9 /l) x cd34 events x1000 cd34 is expressed on ~1-4% of bm cells  ~0.1-1% of umbilical cord blood cells.~0.03- 0.1% in pb</slidetext><slidetext slideid="4TtrJGaU2VT.6MYJzMFQrPD" slidebank="false" type="slide"> mesenchymal cells sources – fatbone marrow     </slidetext><slidetext slideid="4TtrJGaU2VT.5oV8aNoDZ4i" slidebank="false" type="slide">   mesenchymal stem cells: fat and bone marrow marker overlap positive markers negative markerscd 11bcd 14cd 19cd 34cd 45cd 79acd 117 (c-kit)hla-dr cd 10cd 13cd 29cd 49dcd 49ecd 54cd 73 cd 90cd 105cd 106cd166vimentin  </slidetext><slidetext slideid="4TtrJGaU2VT.5fzRBS29zCz" slidebank="false" type="slide"> mesenchymal&#xB;stem cells stro-1+cd90+ cd34-msca-1+cd45-cd271+cd235acd45- cd34- cd90+cd45- cd34- cd271+cd45- cd34- msca1+cd45- cd34- stro1+cd45- cd34- cd235a stro1+</slidetext><slidetext slideid="4TtrJGaU2VT.5hc8VW6tux1" slidebank="false" type="slide"> differentiated stem cells once in place stem cells will likely commit, differentiate, and mature depending on the environment in which they find themselvesarchitecture (2-d vs 3-d)mechanics (stiffness)biology (growth factors)chemistry (drugs or media)</slidetext><slidetext slideid="4TtrJGaU2VT.5WjjKvVPYUm" slidebank="false" type="slide">  mesenchymal stem cell differentiation</slidetext><slidetext slideid="4TtrJGaU2VT.6UB52LjEcRE" slidebank="false" type="slide"> </slidetext><slidetext slideid="4TtrJGaU2VT.6qPM8O1s7Q6" slidebank="false" type="slide">  cardiac stem cell differentiation   proliferate commit differentiate mature integrate</slidetext><slidetext slideid="4TtrJGaU2VT.6lGQaBrdRqb" slidebank="false" type="slide"> heart differentiation markers  stem cell (flk,cd106)cardioblast (gata-4, hand)cardiocyte (a-actinin)mature cardiocyte(b-myosin, a-myosin,ctni)   </slidetext><slidetext slideid="4TtrJGaU2VT.5dkVQYOko08" slidebank="false" type="slide">  potential target combinations exampletarget population publishedvalues (%) brc values (%) referencenumber bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- cd90+ 1±4 0.5243±0.2889 [3] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- cd271+ 2.3±0.8 0.9266±1.2907 [4] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- msca1+ 0.5±0.3 0.331±0.3822 [5] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- stro1+ 0.02 1±0.3207 [6] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- cd235a stro1+   0.1883±0.0130   bone marrow hematopoieticcd34+ cd90+ cd133+ cd45+ cd117+ cd45dim cd34+ 0.0167±0.0178 1.7475±0.6635   bone marrow hematopoieticcd34+ cd90+ cd133+ cd45+ cd117+ cd45dim cd34+ cd117+ 1.7±0.9 0.071±0.0538 [7]  bone marrow hematopoieticcd34+ cd90+ cd133+ cd45+ cd117+ cd45dim cd34+ cd133+ 0.6±0.3 0.8395±0.2384 [8, 9] bone marrow endothelialcd133+cd34+ cd184+cd309+ (kdr+) cd31+ cd45dim cd34+ cd133+ cd309+ (kdr+) &lt;0.05  0.0001±0.1  [10]  bone marrow endothelialcd133+cd34+ cd184+cd309+ (kdr+) cd31+ cd45dim cd34+ cd133+ 0.8±0.1 0.8395±0.2384  [11] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	  cd45dim cd34+ cd133+  0.0001±0.01  0.0013±0.00077  [12] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	 cd34+ cd45dim low ssc &lt;0.1% 0.04±0.007 [13] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	 cd45dim cd34+ cd309+ (kdr+) 0.001±0.06 0.004±0.002 [14] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	 cd45dim cd34+ cd133+ 0.02 0.018±0.002 [12] peripheral blood lymphocytescd45+ cd3+ cd4+ cd19+ cd16+ cd56+ cd8+cd25+ cd127+  cd4+ cd25high cd127dim t inducers  1.4±2.4   1.92±0.57  [15] peripheral blood gcsf mobilizedcd45-cd184+ (cxcr4+) cd45- cd184+ (cxcr4+)  &lt;0.01  0.3702±0.3669  [18] peripheral blood monocytescd14+ cd16dimcd11b+ cd16midtie-2+  cd14+ cd16-  4.5±13.1  5.7±0.67  [16] peripheral blood monocytescd14+ cd16dimcd11b+ cd16midtie-2+ cd14dim cd16+ 0.4±1.1  0.47±0.21 [16] peripheral blood monocytescd14+ cd16dimcd11b+ cd16midtie-2+ cd14+ cd16mid tie-2+ 0.12±3.64 monocytes 0.33±0.14 [17] ex vivo cultured mesenchymalcd45- cd34-cd73+cd90+cd105+  cd45- cd34- cd73+ cd90+ cd105+  &gt;95  &gt;95  [19] ex vivo cultured cardiaclin- cd117+ lin- cd117+ 0.01± 0.05 n/a [20] ex vivo cultured esc/ipslin- cd133+ cd117+ ssea-1+ tra1-81+ ssea-1- ssea-3+ ssea-4+ ssea-3: 10±70 ssea-4: 10±90 ssea-1: 20±50tra-1-81: 10±60 ssea-3:  4.6ssea-4:  82.4ssea-1:  67.2tra-1-81: 77.1  [21]    adult heartsc-kit c-kit   0.3987±0.2976adult mouse   potential target combinations exampletarget population publishedvalues (%) brc values (%) referencenumber bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- cd90+ 1±4 0.5243±0.2889 [3] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- cd271+ 2.3±0.8 0.9266±1.2907 [4] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- msca1+ 0.5±0.3 0.331±0.3822 [5] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- stro1+ 0.02 1±0.3207 [6] bone marrow mesenchymalstro-1+cd90+ cd34-msca-1+cd45-cd271+cd235a cd45- cd34- cd235a stro1+   0.1883±0.0130   bone marrow hematopoieticcd34+ cd90+ cd133+ cd45+ cd117+ cd45dim cd34+ 0.0167±0.0178 1.7475±0.6635   bone marrow hematopoieticcd34+ cd90+ cd133+ cd45+ cd117+ cd45dim cd34+ cd117+ 1.7±0.9 0.071±0.0538 [7]  bone marrow hematopoieticcd34+ cd90+ cd133+ cd45+ cd117+ cd45dim cd34+ cd133+ 0.6±0.3 0.8395±0.2384 [8, 9] bone marrow endothelialcd133+cd34+ cd184+cd309+ (kdr+) cd31+ cd45dim cd34+ cd133+ cd309+ (kdr+) &lt;0.05  0.0001±0.1  [10]  bone marrow endothelialcd133+cd34+ cd184+cd309+ (kdr+) cd31+ cd45dim cd34+ cd133+ 0.8±0.1 0.8395±0.2384  [11] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	  cd45dim cd34+ cd133+  0.0001±0.01  0.0013±0.00077  [12] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	 cd34+ cd45dim low ssc &lt;0.1% 0.04±0.007 [13] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	 cd45dim cd34+ cd309+ (kdr+) 0.001±0.06 0.004±0.002 [14] peripheral blood endothelialcd133+ cd34+ cd184+ (cxcr4+) cd309+(kdr+)cd31+cd45dim low ssc	 cd45dim cd34+ cd133+ 0.02 0.018±0.002 [12] peripheral blood lymphocytescd45+ cd3+ cd4+ cd19+ cd16+ cd56+ cd8+cd25+ cd127+  cd4+ cd25high cd127dim t inducers  1.4±2.4   1.92±0.57  [15] peripheral blood gcsf mobilizedcd45-cd184+ (cxcr4+) cd45- cd184+ (cxcr4+)  &lt;0.01  0.3702±0.3669  [18] peripheral blood monocytescd14+ cd16dimcd11b+ cd16midtie-2+  cd14+ cd16-  4.5±13.1  5.7±0.67  [16] peripheral blood monocytescd14+ cd16dimcd11b+ cd16midtie-2+ cd14dim cd16+ 0.4±1.1  0.47±0.21 [16] peripheral blood monocytescd14+ cd16dimcd11b+ cd16midtie-2+ cd14+ cd16mid tie-2+ 0.12±3.64 monocytes 0.33±0.14 [17] ex vivo cultured mesenchymalcd45- cd34-cd73+cd90+cd105+  cd45- cd34- cd73+ cd90+ cd105+  &gt;95  &gt;95  [19] ex vivo cultured cardiaclin- cd117+ lin- cd117+ 0.01± 0.05 n/a [20] ex vivo cultured esc/ipslin- cd133+ cd117+ ssea-1+ tra1-81+ ssea-1- ssea-3+ ssea-4+ ssea-3: 10±70 ssea-4: 10±90 ssea-1: 20±50tra-1-81: 10±60 ssea-3:  4.6ssea-4:  82.4ssea-1:  67.2tra-1-81: 77.1  [21]    adult heartsc-kit c-kit   0.3987±0.2976adult mouse  </slidetext><slidetext slideid="4TtrJGaU2VT.6GBiioTYGjd" slidebank="false" type="slide">   `~1%  `~1%          baaaaldh substrate   baa-intracellular  baaa: bodipy aminoacetaldehydebaa-: bodipy-aminoacetatealdh: aldehyde dehydrogenase aldh  intracellular fluorescence side scatter cells in pace</slidetext><slidetext slideid="4TtrJGaU2VT.6VpO1F1Gyyk" slidebank="false" type="slide">   hematopoieticendothelialmesenchymal  differentiation potentials in aldh bright fraction  adipo             osteo              chondro      vwf                     lectin              tube formation    dil ac-ldl cd34+cd38-                   cd34+cd117+            colony-forming units                                            storms et al, 1999; gentry et al., 2007 </slidetext><slidetext slideid="4TtrJGaU2VT.679kZPE3b5V" slidebank="false" type="slide"> cell subpopulations in aldh bright fraction marker significantly enriched (p≤0.05) cd34, cd38, cd105, cd117, cd127, cd166, hla-dr significantly depleted (p≤0.05) cd3, cd7, cd19, cd31, cd45, cd73, cd103   marker significantly enriched (p≤0.05) cd34, cd38, cd105, cd117, cd127, cd166, hla-dr significantly depleted (p≤0.05) cd3, cd7, cd19, cd31, cd45, cd73, cd103  gentry et al., 2007</slidetext><slidetext slideid="4TtrJGaU2VT.5XZT6qOTap5" slidebank="false" type="slide"> cell function assays   hirschi k k et al. arterioscler thromb vasc biol 2008;28:1584-1595 copyright © american heart association</slidetext><slidetext slideid="4TtrJGaU2VT.5jNuRZOkfl3" slidebank="false" type="slide"> cfu –hill assay  framingham risk score  hill jm et al. n engl j med. 2003;348:593-600.  r = –47.0p = 0.001 -5	 0	 5	  10	  15	 20 70 colony-forming units                                                              60 50 40 30 20 10 0 framingham risk score  hill jm et al. n engl j med. 2003;348:593-600.  r = –47.0p = 0.001 -5	 0	 5	  10	  15	 20 70 colony-forming units                                                              60 50 40 30 20 10 0 n = 45 males without cad, &gt; 21 years (mean age 50.3)  conclusion: cfu-hill is a biologic marker for vascular function and cumulative cardiovascular risk.</slidetext><slidetext slideid="4TtrJGaU2VT.6q7IHZjzVxu" slidebank="false" type="slide">  cfc assay</slidetext><slidetext slideid="4TtrJGaU2VT.6bsJAqueoeZ" slidebank="false" type="slide"> bone marrow harvest   a cell isolation cfu-f msc  bone marrow harvest   a cell isolation cfu-f msc cfu-f assay  (mscs)cfu-fibroblast (mesodermal cell)</slidetext><slidetext slideid="4TtrJGaU2VT.5m1eBzwAxLa" slidebank="false" type="slide"> example of using brc data &#xB;to better understand results&#xB; question: do cell phenotype or function in bone marrow associate with improvement (or decline) in lvesv? 43  baselinen=54                6 mon=54                baselinen=28                6 mon=28 baselinen=54                6 mon=54                baselinen=28                6 mon=28                change in indexed lves volume by echo bmc placebo</slidetext><slidetext slideid="4TtrJGaU2VT.6CvIU1C45Sy" slidebank="false" type="slide"> lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36  lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36 outcome combinations number of cases (benefit)   cell parameters associated with positive changes in 1,2,or 3 outcomes lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36  lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36 outcome combinations number of cases (benefit)   cell parameters associated with positive changes in 1,2,or 3 outcomes  single, double, or triple cases super responders</slidetext><slidetext slideid="4TtrJGaU2VT.5jEZW6i8qmO" slidebank="false" type="slide"> example of using brc data &#xB;to better understand results&#xB; question: do cell phenotype or function in bone marrow associate with improvement (or decline) in lvesv? 45  baselinen=54                6 mon=54                baselinen=28                6 mon=28 baselinen=54                6 mon=54                baselinen=28                6 mon=28                change in indexed lves volume by echo bmc placebo</slidetext><slidetext slideid="4TtrJGaU2VT.5VbirWS7nB4" slidebank="false" type="slide"> lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36  lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36 outcome combinations number of cases (benefit)   cell parameters associated with positive changes in 1,2,or 3 outcomes lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36  lvef/lvesv/vo2maxn= 17  lvef/lvesvn= 33  lvefn= 46  lvesvn= 51  lvef/ vo2maxn= 19  lvesv/ vo2maxn= 17  vo2maxn= 36 outcome combinations number of cases (benefit)   cell parameters associated with positive changes in 1,2,or 3 outcomes  single, double, or triple cases super responders</slidetext><slidetext slideid="4TtrJGaU2VT.6SSqfmJe5SE" slidebank="false" type="slide"> variable controls cases p-value      esv    cd19+cd11b+ b-cells/mp [31]0.7649(0.3957)* [45]1.0150(0.5806) 0.040       vo2max    cd19+  b-cells [42]9.8083(4.9928) [33]12.6864(6.6637) 0.036 cd45+cd31low epcs [41]25.4409(6.5949) [33]29.0269(7.6885) 0.034 cd45+cd19+  b-cells [42]10.6869(4.7226) [33]13.6903(6.3053) 0.021 cd19+cxcr4+ sdfr/b-cells [42]9.1004(4.3860) [33]12.1684(5.8250) 0.011      lvef    cd45+cd11b+  mp [35]4.0928(2.4799) [43]2.9515(1.7779) 0.021  variable controls cases p-value      esv    cd19+cd11b+ b-cells/mp [31]0.7649(0.3957)* [45]1.0150(0.5806) 0.040       vo2max    cd19+  b-cells [42]9.8083(4.9928) [33]12.6864(6.6637) 0.036 cd45+cd31low epcs [41]25.4409(6.5949) [33]29.0269(7.6885) 0.034 cd45+cd19+  b-cells [42]10.6869(4.7226) [33]13.6903(6.3053) 0.021 cd19+cxcr4+ sdfr/b-cells [42]9.1004(4.3860) [33]12.1684(5.8250) 0.011      lvef    cd45+cd11b+  mp [35]4.0928(2.4799) [43]2.9515(1.7779) 0.021 *[n] mean (sd)  *[n] mean (sd)    cell phenotypes associated with &#xB;single outcome improvements</slidetext><slidetext slideid="4TtrJGaU2VT.5dFN5ZTd9kP" slidebank="false" type="slide">  bm cell phenotype associated with positive changes in a single outcome</slidetext><slidetext slideid="4TtrJGaU2VT.68JnWGVCHjn" slidebank="false" type="slide"> thank you adrian gee, mi biol , phd		micheline resende, phdaaron orozco, phdcharles wellington, rnsarah schneider, bsgraca cabreira, phdxiahon wangbelinda nestor, bsmarj carlson rnclaudia zierold, phd</slidetext></search></nav_data><resource_data description="" /><transcript_data><slidetranscripts><slidetranscript slideid="4TtrJGaU2VT.5XZT6qOTap5" slidebank="false" type="slide" noteswf="presentation_content/notes/5XZT6qOTap5.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;Figure 1. Common methods of “EPC” culture. Culture of colony forming unitHill cells (CFU-Hill, Method A, scale bar=100 um), includes a 5-day process wherein nonadherent peripheral blood mononuclear cells (PB-MNCs) give rise to the colony. Circulating angiogenic cells (CAC, Method B, scale bar=200 um) are the adherent mononuclear cells of a 4- to 7-day culture of PB-MNCs. CAC cultures typically do not display colony formation. Endothelial colony forming cells (ECFCs, Method B, scale bar=400 um) are derived from adherent PB-MNCs cultured for 6 to 21 days in endothelial conditions, and colonies display a cobblestone morphology. Only the ECFC progeny form blood vessels de novo in vivo. Images were collected using a Zeiss Axiovert 2 inverted microscope with 10×/0.25Ph1 CP-ACROMAT (CFU-EC), 32×/0.40Ph1 LD-ACROSTIGMAT (CAC), or 5× CP-ACHROMAT/0.12Ph0 (ECFC) objectives. Images were acquired using a SPOT RT color camera (Diagnostic Instruments) with the manufacturer’s software. Images cropped and scale bars added in Adobe Photoshop version 8.0. Modified from Prater DN et al. Working hypothesis to redefine endothelial progenitor cells. Leukemia. 2007;21:1142.&lt;/font&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript><slidetranscript slideid="4TtrJGaU2VT.6q7IHZjzVxu" slidebank="false" type="slide" noteswf="presentation_content/notes/6q7IHZjzVxu.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;Hematopoietic&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript><slidetranscript slideid="4TtrJGaU2VT.6bsJAqueoeZ" slidebank="false" type="slide" noteswf="presentation_content/notes/6bsJAqueoeZ.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;14-21 days&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript><slidetranscript slideid="4TtrJGaU2VT.5m1eBzwAxLa" slidebank="false" type="slide" noteswf="presentation_content/notes/5m1eBzwAxLa.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;So visually, you can see that individuals can be divided into two groups: cases and controls.  The red lines indicate those who showed an improvement (cases).  The same is true for LVEF and also VO2 max.&lt;br&gt;The results of the analyses of the primary outcomes are as follows.&lt;br&gt;&lt;br&gt;Need p value&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript><slidetranscript slideid="4TtrJGaU2VT.6CvIU1C45Sy" slidebank="false" type="slide" noteswf="presentation_content/notes/6CvIU1C45Sy.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;Here you can see the number of cases where benefits were seen in one, two, or three outcomes.&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript><slidetranscript slideid="4TtrJGaU2VT.5jEZW6i8qmO" slidebank="false" type="slide" noteswf="presentation_content/notes/5jEZW6i8qmO.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;So visually, you can see that individuals can be divided into two groups: cases and controls.  The red lines indicate those who showed an improvement (cases).  The same is true for LVEF and also VO2 max.&lt;br&gt;The results of the analyses of the primary outcomes are as follows.&lt;br&gt;&lt;br&gt;Need p value&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript><slidetranscript slideid="4TtrJGaU2VT.5VbirWS7nB4" slidebank="false" type="slide" noteswf="presentation_content/notes/5VbirWS7nB4.swf">&lt;html&gt;&lt;p align='left'&gt;&lt;textformat leading='1' tabstops='[48, 96]' leftmargin='0' indent='0'&gt;&lt;font face='Microsoft Sans Serif' size='10.3467pt' color='#000000'&gt;Here you can see the number of cases where benefits were seen in one, two, or three outcomes.&lt;/font&gt;&lt;/textformat&gt;&lt;/p&gt;&lt;/html&gt;</slidetranscript></slidetranscripts></transcript_data><glossary_data /><presenters><presenter id="8QmGefOdlsw" photo="presentation_content/6AfDpN7PaV1_8QmGefOdlsw_80_DX112_DY112.swf" mobilephoto="mobile/6AfDpN7PaV1_8QmGefOdlsw_80_DX112_DY112_CX45_CY56.png" name="Doris A. Taylor, PhD" title="" email=""><bioHtml /></presenter></presenters></bwFrame>